32 Stocks Moving In Thursday's Mid-Day Session

Gainers

• Applied Genetic Technologies Corporation AGTC rose 51.4% to $6.30 after the company released a positive midstage readout for its gene therapy to treat an inherited eye disorder. he Cambridge, Massachusetts-based company said six-month data from an ongoing Phase 1/2 study that is evaluating its AAV-based gene therapy in X-linked retinitis pigmentosa (XLRP) showed the product candidate produced durable improvement in visual function six months after dosing.
• Genetic Technologies Limited GENE surged 33.1% to $4.34.
• Five Star Senior Living Inc. FVE surged 21.8% to $4.9315.
• Tiziana Life Sciences PLC TLSA rose 15.8% to $3.16. Tiziana Life Sciences highlighted Phase 1 data showing oral treatment with foralumab was well tolerated.
• ADMA Biologics, Inc. ADMA climbed 15.6% to $4.30 after the company reported preliminary Q4 results.
• DBV Technologies S.A. DBVT shares gained 14.9% to $12.91 after the company reported positive three-year, long-term data from the PEOPLE Phase III Open-label extension study of viaskin peanut in children with peanut allergy.
• Yiren Digital Ltd. YRD surged 14.8% to $6.83.
• Applied Therapeutics, Inc. APLT gained 13.5% to $39.93.
• Lindsay Corporation LNN climbed 13.4% to $109.64 following Q1 results.
• Chico's FAS, Inc. CHS rose 13.3% to $4.2601 after the company raised it Q4 forecast.
• The Peck Company Holdings, Inc. PECK rose 13.2% to $2.74.
• Origin Agritech Limited SEED gained 12% to $6.53.
• Oramed Pharmaceuticals Inc. ORMP rose 11.7% to $5.36.
• OneConnect Financial Technology Co., Ltd. OCFT rose 11.5% to $14.00.
• Safe-T Group Ltd SFET rose 8.7% to $3.11.
• My Size, Inc. MYSZ gained 7.7% to $3.76.
• Snap Inc. SNAP rose 6.2% to $17.69.

Check out these big penny stock gainers and losers

Losers

• Tufin Software Technologies Ltd. TUFN dipped 23.7% to $13.15 after the company announced Q4 sales of $29.5 million-$30.1 million compared to the previous range of $34 million-$38 million.
• Can-Fite BioPharma Ltd. CANF dropped 20.8% to $2.74. Can-Fite announced exercise of warrants for cash proceeds of $2.4 million.
• Bed Bath & Beyond Inc. BBBY fell 19.4% to $13.40 after the company reported weaker-than-expected results for its third quarter. The company expects sales and profitability to remain pressured and withdrew its 2019 fiscal year guidance.
• Renren Inc RENN dropped 17.7% to $1.95.
• Solid Biosciences Inc SLDN fell 14.1% to $3.80.
• Kura Sushi USA Inc KRUS dropped 14% to $24.78.
• Acuity Brands, Inc. AYI fell 10.2% to $128.51 after the company reported worse-than-expected Q1 EPS and sales results.
• Cellect Biotechnology Ltd – ADR APOP dropped 9.7% to $2.92.
• Kohl's Corporation KSS dropped 9.2% to $44.84 after the company reported November/December sales results down from last year.
• Sellas Life Sciences Group Inc SLS fell 9% to $3.57. SELLAS Life Sciences priced 1.64 million common shares for gross proceeds $6.5 million.
• Innate Pharma S.A. IPHA fell 8.4% to $6.96. Innate Pharma said that the FDA put TELLOMAK trial on partial clinical hold.
• Mirati Therapeutics, Inc. MRTX shares fell 8.4% to $95.86 after the company announced a $250 million common stock offering.
• Camber Energy, Inc. CEI fell 6.5% to $3.01.
• Antero Resources Corporation AR fell 5.7% to $2.4050.
• AEterna Zentaris Inc. AEZS fell 4.1% to $1.0750 after the company received a Nasdaq notice regarding the minimum bid price requirement.